Shire Pharmaceuticals (SHPG) Announces Third Annual Scholarship Program for Individuals With ADHD
11/6/2012 9:53:36 AM
PHILADELPHIA--(BUSINESS WIRE)--Shire, a global specialty biopharmaceutical company, is pleased to announce that it has launched its 2013 ADHD Scholarship Program. The program is for individuals in the United States diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD) who are pursuing higher education at a college, vocational school or technical school. Since the start of the program in 2011, Shire has announced 75 national scholarship award recipients and 10 employee award recipients. To see a full list of scholarship recipients, visit www.ShireADHDscholarship.com.